assets (ROA) decreased from 1.46% to 0.66% and the return on equity (ROE) decreased from 1.87% to 0.84% and earnings per share (EPS) decreased from 0.91 Baht/share to 0.40 Baht/share. For the nine-month

+ %')'#+"#$./+.'* !#[/+(#$PKL ,"' #$./+.'* % *#%"O* (cost income ratio) +" 58% %!' )'#+"#$O*./+bK$% *#%"O*P K 91% .')"#" &'.#% &P* M)* (return on equity) !+ %'#$./+.'*̀?#! #" !()*&'.#%&P* M)*P#$ 'M'#$./+.%O**! #" .''#$O*./+ ' 9

Statement year ended March 31, 2020 Return on Assets and Return on Equity of 1Q’20 deteriorated yoy. because of high profit of base year which was driven by both the hospital business and extra transaction of

Statement year ended December 31, 2019 Both of return on assets and return on equity of 4Q19 improved yoy. driven by the sustainable profit and higher dividend payout ratio. From the financial risk

IPO proceeds. Return on Assets and Return on Equity improved from 6%-8% during 9M16 to 11%-12% yoy. It was driven by the outstanding profit and the Company’s consistent dividend payment. In respect of

% Non-controlling interest 75.40 50.81 48% Total shareholders' equity 1,666.39 1,541.05 8% Page 4 of 4 Ratio Analysis Financial Statement year ended December 31, 2017 Return on Assets and Return on Equity

, Return on Assets and Return on Equity improved from 10% and 12% in 1Q’17 to 12% and 14% yoy. They were driven by the outstanding profit of both the Company and subsidiary. In respect of liquidity ratio in

% % ChangeFinancial Position : Consolidated Balance Sheet Page 4 of 4 Ratio Analysis of Financial Statement year ended September 30, 2019 Both of return on assets and return on equity of 3Q19 improved yoy. driven by

31 Mar 17 Return on Equity (%) 16.5% 18.9% Return on Assets (%) 12.7% 14.4% Collection period (days) 78 79 Inventory Days 46 44 Account Payable Days 91 101 Cash Cycle (days) 33 22 Leverage & Financial

increased by Baht 256 million, driven by increase of profit during the period, partly offset by dividend payment. Key Financial Performance Q2 2018 Q3 2018 Q4 2018 Q1 2019 Q2 2019 Return on equity (ROE) 18.90